Protocols · Growth Hormone
Without the drug-affinity complex, CJC-1295 is a stabilised GHRH fragment with a short half-life, designed to produce a pulse rather than a sustained elevation. The published record is small — pharmacology studies of GHRH analogue variants rather than a full trial programme.
Read this first
Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.
Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.
The four amino-acid substitutions exist to resist DPP-4 degradation, not to extend duration.
Frequent administration is used precisely because the molecule does not persist.
These figures match the published chart for this compound on peptidedosages.com, including the reconstitution volume, resulting concentration, insulin-syringe units and the staged schedule. Educational reference only — not instructions, and not medical advice.
CJC-1295 (no DAC) · 5 mg Vial
CJC-1295 NO DAC is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols. A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL. This information is for research and educational use only.
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units (0.06 mL) |
| Weeks 3–4 | 150 mcg | 9 units (0.09 mL) |
| Weeks 5–6 | 200 mcg | 12 units (0.12 mL) |
| Weeks 7–12 | 250–300 mcg | 15–18 units (0.15–0.18 mL) |
The same arithmetic for every vial size CJC-1295 (no DAC) is supplied in, using a fixed 3 ml of bacteriostatic water. One unit on a U-100 insulin syringe is 0.01 ml, so the unit column below is simply the volume that carries the reported amount. Educational arithmetic only — not instructions, and not medical advice.
CJC-1295 (no DAC) · 3 ml bacteriostatic water
| Vial size | Concentration | Per 1 unit | 100 mcg = | 300 mcg = |
|---|---|---|---|---|
| 2 mg | 0.67 mg/ml | 7 mcg | 15 units | 45 units |
| 5 mg | 1.67 mg/ml | 17 mcg | 6.0 units | 18 units |
| 10 mg | 3.33 mg/ml | 33 mcg | 3.0 units | 9.0 units |
Unit columns use the range reported for this compound (100 mcg–300 mcg). Only the vial sizes this compound is actually supplied in are shown, and every figure assumes exactly 3 ml of bacteriostatic water. For any other volume, use the reconstitution calculator.
A 5 mg vial in 2 mL of bacteriostatic water gives 2.5 mg/mL; 0.04 mL draws 100 µg.
Open the reconstitution calculatorNo peer-reviewed primary literature reporting administered quantities exists for this item. Anything circulating online about quantities is anecdote rather than evidence, and this page will not reproduce it. The database links below are kept so you can check for yourself as new work is published.
Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.
Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.
